SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS

The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder in a canine animal, preferably wherein the metabolic disorder is one or more selected from the group consisting of: ketoacidos...

Full description

Saved in:
Bibliographic Details
Main Authors REICHE, Dania Birte, KLEY, Saskia
Format Patent
LanguageEnglish
Hungarian
Published 28.12.2023
Subjects
Online AccessGet full text

Cover

Loading…